We screened DEGs of RNA-seq between 43 DNMT3A mutation and 127 wild-type AML patients with the criteria of log2  | fold change (FC) | ≥1 and P value < 0.05. This evidence concerns the gene DNMT3A and acute myeloid leukemia.